📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model. (2020)

First Author: McAdoo SP

Attributed to: The role of P2X7 in Autoimmune Vasculitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.kint.2019.12.014

PubMed Identifier: 32305129

Publication URI: http://europepmc.org/abstract/MED/32305129

Type: Journal Article/Review

Volume: 97

Parent Publication: Kidney international

Issue: 6

ISSN: 0085-2538